Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases.
Document Type
Journal Article
Publication Date
6-13-2017
Journal
Proceedings of the National Academy of Sciences of the United States of America
Volume
114
Issue
24
Inclusive Pages
E4782-4791
DOI
10.1073/pnas.1703683114
Keywords
Animals; Cell Cycle Checkpoints; DNA Damage; Disease Models, Animal; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Etoposide; Humans; Immune System Diseases; Lymphocyte Activation; Lymphohistiocytosis, Hemophagocytic; Mice; Mice, 129 Strain; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Multiple Sclerosis; Proto-Oncogene Proteins c-mdm2; Signal Transduction; T-Lymphocytes; Tumor Suppressor Protein p53
APA Citation
McNally, J., Millen, S., Chaturvedi, V., Lakes, N., Terrell, C., Greenberg, J., Ladisch, S., & +several additional authors (2017). Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases.. Proceedings of the National Academy of Sciences of the United States of America, 114 (24). http://dx.doi.org/10.1073/pnas.1703683114
Peer Reviewed
1
